The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivity.

cue reactivity impulsivity nicotine randomised controlled trial smoking

Journal

Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440

Informations de publication

Date de publication:
07 2021
Historique:
revised: 02 10 2020
received: 19 03 2020
accepted: 07 10 2020
pubmed: 4 11 2020
medline: 15 12 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

Impulsivity may be a risk factor that increases vulnerability to nicotine dependence. However, nicotine exposure itself may directly increase impulsivity. This is a secondary analysis of the first study in a controlled laboratory setting, which assessed the effects of nicotine administration (acute and repeated) and exposure to smoking cues on behavioural impulsivity in humans (ClinicalTrials.gov Identifier: NCT01395797). Twenty-seven smokers completed three tasks to assess behavioural impulsivity (the Immediate Memory Task and the Delayed Memory Task assessing response initiation, and the GoStop Task assessing response inhibition) following: (i) 4 days of cigarette smoking (nicotinised or denicotinised cigarette); (ii) acute cigarette smoking (nicotinised); and (iii) exposure to smoking-related cues. Four days of nicotinised cigarette smoking (vs. denicotinised) did not significantly increase Immediate Memory Task, Delayed Memory Task and GoStop scores. However, acute cigarette smoking increased GoStop impulsivity, but only following 4 days of smoking nicotinised cigarettes (P < 0.05). Exposure to smoking-related cues had no statistically significant effect on impulsivity. Our results suggest that repeated nicotine exposure may sensitise subsequent acute nicotine effects on behavioural impulsivity in heavy smokers.

Identifiants

pubmed: 33140460
doi: 10.1111/dar.13206
pmc: PMC8088442
mid: NIHMS1683803
doi:

Banques de données

ClinicalTrials.gov
['NCT01395797']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

864-868

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA031022
Pays : United States
Organisme : NIDA NIH HHS
ID : R25 DA035161
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007294
Pays : United States

Informations de copyright

© 2020 Australasian Professional Society on Alcohol and other Drugs.

Références

Behav Res Methods Instrum Comput. 2002 Aug;34(3):391-8
pubmed: 12395555
Psychopharmacology (Berl). 2006 Mar;184(3-4):547-52
pubmed: 16175402
Science. 2001 Jun 29;292(5526):2499-501
pubmed: 11375482
Psychopharmacology (Berl). 2008 Nov;200(4):529-44
pubmed: 18604520
Biol Psychiatry. 2008 Feb 1;63(3):301-8
pubmed: 17884016
Arch Gen Psychiatry. 1986 Mar;43(3):289-94
pubmed: 3954551
J Addict Dis. 2014;33(2):83-93
pubmed: 24784229
Psychopharmacology (Berl). 2007 Apr;191(3):587-98
pubmed: 16972104
Neuropsychopharmacology. 2014 Jan;39(2):254-62
pubmed: 24121188
Rev Neurosci. 2011;22(1):75-84
pubmed: 21615262
Brain. 2000 Nov;123 ( Pt 11):2189-202
pubmed: 11050020
Sci Rep. 2020 May 22;10(1):8570
pubmed: 32444782
Nicotine Tob Res. 2008 Aug;10(8):1397-404
pubmed: 18686188
Addict Behav. 2016 Nov;62:145-51
pubmed: 27376882
Am J Psychiatry. 2001 Nov;158(11):1783-93
pubmed: 11691682
Pers Individ Dif. 2015 Apr;76:68-74
pubmed: 25844002
Am J Psychiatry. 1998 Aug;155(8):1009-15
pubmed: 9699686
J Child Psychol Psychiatry. 2003 Nov;44(8):1145-57
pubmed: 14626456
Drug Alcohol Depend. 2018 Apr 1;185:149-167
pubmed: 29453142
Behav Cogn Neurosci Rev. 2004 Dec;3(4):261-75
pubmed: 15812110
Behav Processes. 2004 Jan 30;65(1):35-42
pubmed: 14744545
Physiol Behav. 2007 Jan 30;90(1):54-8
pubmed: 17049956
J Neurosci. 2004 Jan 28;24(4):773-80
pubmed: 14749421
Front Psychiatry. 2013 Jul 16;4:67
pubmed: 23874307
Pharmacol Biochem Behav. 2017 Dec;163:90-100
pubmed: 29020601
Am J Addict. 2014 May-Jun;23(3):211-7
pubmed: 24724877
Behav Pharmacol. 2010 Dec;21(8):754-64
pubmed: 20944502
Int J Neuropsychopharmacol. 2014 Oct 31;18(2):
pubmed: 25552431
Behav Res Methods. 2005 Feb;37(1):82-90
pubmed: 16097347

Auteurs

Suky Martinez (S)

Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, USA.
Translational Research Training Program in Addiction, City College of New York, Columbia University Irving Medical Center, New York, USA.
Gordon F. Derner School of Psychology, Adelphi University, Garden City, USA.

Jermaine D Jones (JD)

Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, USA.

Nehal P Vadhan (NP)

Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra University/Northwell Health, Hempstead, USA.
Behavioral Science Institute, Feinstein Institute for Medical Research, Manhasset, USA.

Laura Brandt (L)

Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, USA.

Sandra D Comer (SD)

Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, USA.

Adam Bisaga (A)

Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH